Penumbra, Inc. to Present at the BofA Securities 2025 Health Care Conference
Get Alerts PEN Hot Sheet
Join SI Premium – FREE
Event: BofA Securities 2025 Health Care Conference
Date:
Time:
A webcast of the presentation can be accessed on the "Events and Presentations" section under the "Investors" tab of the company's website at www.penumbrainc.com. The webcast will be available on the company's website for at least two weeks following the event.
About Penumbra
Penumbra, Inc., the world's leading thrombectomy company, is focused on developing the most innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia. Our broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe with speed, safety and simplicity. By pioneering these innovations, we support healthcare providers, hospitals and clinics in more than 100 countries, working to improve patient outcomes and quality of life. For more information, visit www.penumbrainc.com and connect on Instagram, LinkedIn and X.
Investor Relations
Penumbra, Inc.
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/penumbra-inc-to-present-at-the-bofa-securities-2025-health-care-conference-302438503.html
SOURCE Penumbra, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sectra's three-month interim report: Growing cloud recurring revenue
- Teledyne Qioptiq Receives First Option from Germany for Additional PHOENIX-XR Cooled Thermal Weapon Sights Valued at More Than $21 Million
- LaserPecker Set to Unveil U1 at IFA 2026: Live Demos of Intelligent UV Laser Engraving
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share